Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study.

导出 LinkOut

翻译打印收藏纠错

作者： Uwe,Bieri ^[1] ; Dominik,Enderlin ^[1] ; Lorenz,Buser ^[2] ; Marian S,Wettstein ^[1] ; Daniel,Eberli ^[1] ; Holger,Moch ^[2] ; Thomas,Hermanns ^[1] ; Cédric,Poyet ^[1]

作者单位： Department of Urology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland. ^[1] Department of Pathology and Molecular Pathology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland. ^[2]

关键词 biomarker bladder cancer digital pathology immunoscore prognosis progression

DOI 10.3389/fonc.2022.964672

PMID 36212478

发布时间 2023-11-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

964672页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除